Texas Permanent School Fund Corp Increases Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Texas Permanent School Fund Corp raised its position in Addus HomeCare Co. (NASDAQ:ADUS) by 0.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 14,089 shares of the company’s stock after purchasing an additional 82 shares during the period. Texas Permanent School Fund Corp owned 0.08% of Addus HomeCare worth $1,636,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Choreo LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter worth $340,000. Wedbush Securities Inc. raised its holdings in shares of Addus HomeCare by 9.6% during the 2nd quarter. Wedbush Securities Inc. now owns 3,305 shares of the company’s stock worth $384,000 after acquiring an additional 290 shares during the period. Quest Partners LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter worth $31,000. Arizona State Retirement System raised its holdings in shares of Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after acquiring an additional 87 shares during the period. Finally, Victory Capital Management Inc. raised its holdings in shares of Addus HomeCare by 136.5% during the 2nd quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock worth $9,294,000 after acquiring an additional 46,199 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Activity at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. Insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on ADUS. Oppenheimer lifted their price target on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a report on Wednesday, August 7th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Finally, Stephens reissued an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $127.57.

Addus HomeCare Stock Up 0.0 %

Shares of NASDAQ ADUS opened at $132.52 on Thursday. The firm has a market cap of $2.40 billion, a PE ratio of 32.88, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The business has a 50 day moving average price of $126.34 and a two-hundred day moving average price of $113.55. Addus HomeCare Co. has a fifty-two week low of $78.35 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same quarter in the previous year, the business earned $0.94 EPS. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.